[The assessment of the efficacy of calcium antagonists in the treatment of children with repeated episodes of the broncho-obstructive syndrome].
Overall seventy-five schoolchildren with a history of no less than 4 episodes of impassability commonly against the afebrile background were examined. The results obtained suggest that the greatest reduction in the relative risk of bronchial unspecific hyperreactivity manifestations with calcium antagonists being ingested occurs in those children experiencing recurrent episodes of bronchial obstruction in the presence of marked lability of the bronchi that is commonly associated with the atopic genesis of their obstruction.
Ginguliak
N G
NG
Bezrukov
L A
LA
Bogutskaia
N K
NK
Koloskova
E K
EK
Shvygar
L V
LV
D000280:Administration, Inhalation; D016535:Bronchial Hyperreactivity / Q000188:drug therapy / Q000503:physiopathology; D001991:Bronchitis / Q000188:drug therapy* / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D002648:Child; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D012008:Recurrence
D002121:Calcium Channel Blockers
Otsenka éffektivnosti antagonistov kal'tsiia v lechenii deteĭ s povtornymi épizodami bronkhoobstruktivnogo sindroma.